OraSure Technologies Inc (OSUR)
5.355
+0.10
(+1.81%)
USD |
NASDAQ |
Apr 26, 12:17
OraSure Technologies Price to Book Value: 0.9176 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 0.9013 |
| April 24, 2024 | 0.9424 |
| April 23, 2024 | 0.9476 |
| April 22, 2024 | 0.9167 |
| April 19, 2024 | 0.9047 |
| April 18, 2024 | 0.8996 |
| April 17, 2024 | 0.8996 |
| April 16, 2024 | 0.8945 |
| April 15, 2024 | 0.927 |
| April 12, 2024 | 0.9459 |
| April 11, 2024 | 0.9887 |
| April 10, 2024 | 0.9921 |
| April 09, 2024 | 1.016 |
| April 08, 2024 | 1.014 |
| April 05, 2024 | 1.021 |
| April 04, 2024 | 1.030 |
| April 03, 2024 | 1.059 |
| April 02, 2024 | 1.030 |
| April 01, 2024 | 1.042 |
| March 28, 2024 | 1.054 |
| March 27, 2024 | 1.052 |
| March 26, 2024 | 1.042 |
| March 25, 2024 | 1.066 |
| March 22, 2024 | 1.083 |
| March 21, 2024 | 1.086 |
| Date | Value |
|---|---|
| March 20, 2024 | 1.117 |
| March 19, 2024 | 1.153 |
| March 18, 2024 | 1.165 |
| March 15, 2024 | 1.140 |
| March 14, 2024 | 1.179 |
| March 13, 2024 | 1.205 |
| March 12, 2024 | 1.210 |
| March 11, 2024 | 1.184 |
| March 08, 2024 | 1.239 |
| March 07, 2024 | 1.249 |
| March 06, 2024 | 1.194 |
| March 05, 2024 | 1.200 |
| March 04, 2024 | 1.181 |
| March 01, 2024 | 1.246 |
| February 29, 2024 | 1.233 |
| February 28, 2024 | 1.325 |
| February 27, 2024 | 1.205 |
| February 26, 2024 | 1.201 |
| February 23, 2024 | 1.193 |
| February 22, 2024 | 1.146 |
| February 21, 2024 | 1.176 |
| February 20, 2024 | 1.164 |
| February 16, 2024 | 1.152 |
| February 15, 2024 | 1.176 |
| February 14, 2024 | 1.185 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5401
Minimum
Jun 13 2022
3.822
Maximum
May 11 2020
1.600
Average
1.573
Median
Price to Book Value Benchmarks
| Abbott Laboratories | 4.831 |
| Integra Lifesciences Holdings Corp | 1.404 |
| Insulet Corp | 15.90 |
| Perspective Therapeutics Inc | 12.14 |
| Xtant Medical Holdings Inc | 2.333 |
Price to Book Value Related Metrics
| PE Ratio | 7.438 |
| PS Ratio | 0.9793 |
| Price to Free Cash Flow | 3.025 |
| Price | 5.355 |
| Earnings Yield | 13.45% |
| Market Cap | 395.18M |
| Operating PE Ratio | 9.146 |
| Normalized PE Ratio | 6.336 |